Eye Adult Changes in Thought (Eye ACT) study: Settings and report on the inaugural cohort

• Published in: Alzheimer's & dementia 2024-12, Vol.20 (S2), p.n/a
• Main Authors: Ferguson, Alina N, Takahashi, Missy, Pope, Beth, Schaaf, Beverly, Cooper, Julie, Kam, Jason, Brush, Michael, Gibbons, Laura E., Lee, Aaron Y, Arteburn, David, Larson, Eric B, Crane, Paul K., Lee, Cecilia S
• Format: Article
• Language: English
• Subjects: Biomarkers
• ISSN: 1552-5260; 1552-5279
• DOI: 10.1002/alz.083941

Background To describe the settings and compare demographic and baseline clinical factors of the inaugural Eye Adult Changes in Thought (ACT) study participants. Method Adult Changes in Thought (ACT) is an ongoing cohort study of older adults (≥ 65 years) randomly recruited from Kaiser Permanente Washington who were cognitively normal at enrollment and followed biennially for the onset of Alzheimer’s disease since 1994. Cognitive testing included the Cognitive Abilities Screening Instrument scored using Item Response Theory (CASI‐IRT) with other measures of cognition. Since December 2021, the Eye ACT study has recruited from the parent ACT study and assessed visual function, intraocular pressure, and multimodal retinal imaging. Eye ACT is unique because participants may be evaluated at the research clinic or in their homes. We compared demographic and clinical characteristics of Eye ACT versus parent ACT participants, and within Eye ACT, participants seen in research clinics versus those seen at home. Result Compared to current ACT participants (N=1868), Eye ACT participants (N=330) were younger, newer to ACT, and had more years of education at ACT enrollment. At their latest assessment, Eye ACT participants reported better cardiovascular health (lower rates of cardiovascular disease, cerebrovascular disease, and hypertension, p‐values all